Elucidating the specific pharmacological mechanism of action (MOA) of naturally happening compounds may be tough. While Tarselli et al. (60) made the primary de novo artificial pathway to conolidine and showcased this naturally occurring compound efficiently suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic target https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers